IG
IVERS-READ GILLIAN C Autre
Other F
US US · SEC (Form 4)
Explore the complete record of transactions filed by IVERS-READ GILLIAN C, Autre. Director active across 1 companies, notably Clovis Oncology, Inc.. Cumulatively, 17 disclosures have been published. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 17 total
5,062 shares
Common Stock
SEC:0000899243-22-020944:0 · 1 Jun 2022
3,749 shares
Common Stock
SEC:0000899243-22-016297:0 · 1 May 2022
688 shares
Common Stock
SEC:0000899243-22-009065:0 · 1 Mar 2022
3,750 shares
Common Stock
SEC:0000899243-22-004577 · 1 Feb 2022
3,750 shares
Common Stock
SEC:0000899243-22-004577:0 · 1 Feb 2022
687 shares
Common Stock
SEC:0000899243-21-046767 · 1 Dec 2021
687 shares
Common Stock
SEC:0000899243-21-046767:0 · 1 Dec 2021
3,749 shares
Common Stock
SEC:0000899243-21-042709 · 1 Nov 2021
3,749 shares
Common Stock
SEC:0000899243-21-042709:0 · 1 Nov 2021
688 shares
Common Stock
SEC:0000899243-21-035116 · 1 Sept 2021
688 shares
Common Stock
SEC:0000899243-21-035116:0 · 1 Sept 2021
3,749 shares
Common Stock
SEC:0000899243-21-031447 · 1 Aug 2021
3,749 shares
Common Stock
SEC:0000899243-21-031447:0 · 1 Aug 2021
687 shares
Common Stock
SEC:0000899243-21-021854 · 1 Jun 2021
687 shares
Common Stock
SEC:0000899243-21-021854:0 · 1 Jun 2021
3,749 shares
Common Stock
SEC:0000899243-21-018279 · 1 May 2021
3,749 shares
Common Stock
SEC:0000899243-21-018279:0 · 1 May 2021
About IVERS-READ GILLIAN C Gillian C Ivers-Read is an executive at Clovis Oncology, Inc.